patent infringement
Novartis Wins One Step in the Patent Dance
With this decision, Novartis said it expects no generic versions of the drug in the U.S. market for at least the ...
JANUARY 7, 2022
FDA’s Dr. Gottlieb Chastises Big Pharma for Biosimilar Entry Delays
Of the 11 biosimilars approved by the FDA, only three have reached the U.S. market.
JULY 20, 2018
ViiV Files Suit Against Gilead Over HIV Drug Patents
ViiV claims bictegravir infringes on its patent covering dolutegravir and many other compounds that include ...
FEBRUARY 8, 2018
Load more